Hutchison China MediTech Limited (NASDAQ: HCM) has declared today that it has secured the investment of $100 million. The pharmaceutical company has inked a deal with CPP Investments. As per the agreement, HCM will sell US$100 million of shares at a price equivalent to US$30 per ADS through a private offering to CPP Investments.

Chi-Med will get all profits from this private offering of the equivalent of 3,333,334 ADSs. The company is intending to use the profits to support its continuing clinical advancement and study. As per the deal, HCM will allot 16,666,670 ordinary shares, par value US $0.10 each. HCM is also preparing to launch both savolitinib & surufatinibin in China after winning permission.

Hutchison China MediTech Limited (HCM) has seen some recent volatility in the market and its common shares closed trading at $30.42 yesterday. People are starting to take notice of HCM as the common shares traded as high as $31.79 and as low as $30.28 in the prior market session.

Hutchison China MediTech Limited (HCM) average trading volume is 202.58K. However, in the prior market session Hutchison China MediTech Limited (HCM) exchanged 69,550 shares. The 1st support level on HCM is $29.37 and the 1st resistance level on HCM is $34.65. HCM fifty day moving average is $31.74 and HCM 200-day moving average is $28.77.

Hutchison China MediTech Limited (HCM) current performance has been specified by the recent movement in HCM common shares. HCM has performed -4.13% over the past 30 days, HCM has performed -7.09% over the past 3 months and HCM has shown 30.67% over the past 12 months. Hutchison China MediTech Limited (HCM) has a 52 week range of $14.74 to $34.90. Hutchison China MediTech Limited (HCM) is trading 106.38% from its 52 week low and -12.84% from its 52 week high. Hutchison China MediTech Limited (HCM) is indicating a 1.66% short float indicating the amount short in the float.

HCM has 142.20M shares outstanding and 62.17M shares in the float. Hutchison China MediTech Limited (HCM) presently has a market cap of $4.33B. and projected EPS next year is -1.20%. The market cap of Hutchison China MediTech Limited (HCM) at $4.33B represents how many People own shares of HCM and is based on the last price ($30.42) of HCM and the amount of shares outstanding (142.20M) with Hutchison China MediTech Limited (HCM).

Hutchison China MediTech Limited (HCM) has aggregate cash (mrq) of 281.01M, aggregate cash per share (mrq) of 2.05, aggregate debt of HCM stands at 33.29M and aggregate debt/equity (mrq) is 9.07. . Hutchison China MediTech Limited (HCM) operational cash flow (ttm) is -79.24M, HCM leveraged free cash flow (ttm) is -97.72M.

HCM is trading -1.85% below (bearish) its SMA20, -5.88% below (bearish) its SMA50 and 14.31% above (bullish) its SMA200.